Drug Labeling Must Be Controlled By Sponsors, Not FDA, Petition Says
This article was originally published in The Tan Sheet
Executive Summary
Sponsors should have exclusive control over the "intended uses" of drugs unless exceptional circumstances exist, a Bennett, Turner & Coleman citizen petition states.